The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Allergy Panel 11 Mold Group
Also known as: Chaetomium globosum m208 IgE
Also known as: Penicillium notatum m1 IgE
Also known as: Stachybotrys chartarumatra RGm24 IgE
The Mast Cell Mold IgE Panel panel contains 5 tests with 9 biomarkers.
The Mast Cell Mold IgE Panel is a comprehensive panel designed to detect specific IgE antibodies in a patient's blood, which are indicative of an allergic response to various molds. This test is crucial for individuals who exhibit symptoms of mold allergy or have a known hypersensitivity to mold spores, as it can guide appropriate avoidance and management strategies. The tests included in this panel are:
Allergy Panel 11, Mold Group: This broad test checks for IgE antibodies against a group of common molds, helping to pinpoint the specific mold allergens causing symptoms.
Chaetomium globosum (m208) IgE: This test measures the IgE antibodies specific to Chaetomium globosum, a mold commonly found in water-damaged buildings and associated with a range of respiratory issues.
PENICILLIUM GLABRUM (P. FREQUENTANS)(M209) IGE: This test is for the detection of IgE antibodies against Penicillium glabrum (also known as P. frequentans), a species of fungus found in various environments that can cause allergic reactions.
Penicillium notatum (m1) IgE: Targets the IgE antibodies to Penicillium notatum, the original source of the antibiotic penicillin, which is also a common indoor allergen.
Stachybotrys chartarum/atra (RGm24) IgE: This test looks for antibodies against Stachybotrys chartarum, also known as black mold, which is notorious for its association with sick building syndrome and various health problems when inhaled.
Patients undergoing this test will have a small sample of blood drawn, which will then be analyzed in a laboratory for the presence of IgE antibodies to the specific molds listed. The results can help allergists and other healthcare providers develop a treatment plan that may include environmental controls, medications, or immunotherapy to manage the allergic response.